Zoledronic Acid Injection
Product Images NDC 69367-190

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 69367-190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Acid 01)

Chemical structure of zoledronic acid illustrating its bisphosphonate backbone with nitrogen-containing heterocyclic ring and associated phosphate groups, including a water molecule. The diagram shows molecular connectivity relevant to the active ingredient.*

FDA Label Image

Figure 1 (Acid 02)

A bar chart comparing the proportion of complete responders by day 10 in pooled HCM studies between Zoledronic Acid Injection 4 mg and Pamidronate 90 mg. The chart shows higher response rate for Zoledronic Acid with a statistically significant p-value of 0.002.*

FDA Label Image

Principal Display Panel (5 mL Vial Carton)

Packaging label for Zoledronic Acid Injection 4 mg/5 mL (0.8 mg/mL) by Westminster Pharmaceuticals, LLC. The label indicates a 5 mL single-dose vial for intravenous use. Important storage and usage instructions, barcodes, dosage warnings, and manufacturer details are also shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.